We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

By LabMedica International staff writers
Posted on 15 Aug 2023
Print article
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence among women. The multifaceted nature of osteoporosis, influenced by both genetic and environmental factors, increases the risk of bone fractures. Early intervention is vital to reduce the consequences of osteoporosis, yet current diagnostic techniques fall short of enabling early detection of this ailment. Now, researchers have developed a biosensor with the potential to identify those at the highest risk of osteoporosis, using less than a drop of blood.

Dual-energy X-ray absorptiometry, the prevalent method to assess changes in bone mineral density, is not sensitive enough to detect density loss until considerable damage has already been done. A number of genomic studies have found specific genetic variations, referred to as single nucleotide polymorphisms (SNPs), which correlate with a higher osteoporosis risk. Building upon these findings, a research team from Universitat Rovira i Virgili (Tarragona, Spain) set out to create a portable electrochemical device to rapidly detect five such SNPs in finger-prick blood samples, enabling early diagnosis of osteoporosis.

Central to the device is an electrode array housing DNA fragments corresponding to each SNP. The application of lysed whole blood to the array facilitates the binding of any matching DNA sequences with the SNPs. Amplification takes place with the incorporation of ferrocene-labeled recombinase polymerase, facilitating electrochemical detection. This innovative platform enabled the identification of osteoporosis-associated SNPs in 15 human blood samples, with validation successfully done against alternative methods. Elimination of the need to extract DNA from the blood streamlines the analysis, making it rapid (approximately 15 minutes) and cost-effective (less than $0.5 per SNP).

In addition to its rapid results and affordability, the device offers portability and ready accessibility, making it ideally suited for point-of-care scenarios instead of being confined to centralized laboratories. The technology's versatility extends its ability to be adapted for the detection of other SNPs, as demonstrated previously by the researchers in identifying drug resistance in Tuberculosis mycobacterium from sputum and predicting cardiomyopathy risk from blood samples. Although the device does not directly diagnose osteoporosis, it has the potential to assist physicians in identifying individuals who require closer monitoring for the condition.

Related Links:
Universitat Rovira i Virgili

New
Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
New
Gold Supplier
Melanoma Panel
UltraSEEK Melanoma Panel
New
C. difficile Test
Simplexa C. difficile Universal Direct Kit
New
Pregnancy Test
Viola

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.